malondialdehyde has been researched along with Leukemia, Prolymphocytic, B-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fahrmann, JF; Hardman, WE | 1 |
1 other study(ies) available for malondialdehyde and Leukemia, Prolymphocytic, B-Cell
Article | Year |
---|---|
Omega 3 fatty acids increase the chemo-sensitivity of B-CLL-derived cell lines EHEB and MEC-2 and of B-PLL-derived cell line JVM-2 to anti-cancer drugs doxorubicin, vincristine and fludarabine.
Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Arachidonic Acid; Cell Line, Tumor; Docosahexaenoic Acids; Doxorubicin; Drug Resistance, Neoplasm; Eicosapentaenoic Acid; G2 Phase Cell Cycle Checkpoints; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic, B-Cell; Lipid Peroxidation; Malondialdehyde; Organ Specificity; Reactive Oxygen Species; Vidarabine; Vincristine; Vitamin E | 2013 |